New York S 3347: Relates to the availability of buprenorphine in opioid treatment programs

Status: REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: S 3347

Sponsors: Nathalia Fernandez

View New York S 3347 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.